Related Experiment Videos
Access to investigational drugs for treatment purposes
S L Nightingale1, C A Kimbrough, P H Rheinstein
1U.S. Food and Drug Administration, Rockville, Maryland.
American Family Physician
|September 15, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Genome-wide association study of dermatophytosis in the UK Biobank cohort.
Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Cannabis smoking and age-related macular degeneration in the UK Biobank cohort.
Journal francais d'ophtalmologie·2022
Diabetes, cigarette smoking and transcription factor 7-like 2 (Tcf7L2) in the UK Biobank cohort.
Bulletin de l'Academie nationale de medecine·2022
Cannabis smoking and glaucoma in the UK Biobank cohort.
Journal francais d'ophtalmologie·2022
Marijuana smoking and cataract.
Journal francais d'ophtalmologie·2022
Overview of the US Food and Drug Administration's reform legislation.
Clinical therapeutics·1999
Climate-Smart Health Care: Role of the Family Physician.
American family physician·2026
Evaluation of the Painful Eye.
American family physician·2026
Knee Pain in Adults and Adolescents: The Initial Evaluation.
American family physician·2026
Atypical Moles.
American family physician·2026
Amenorrhea: A Practical Approach to Diagnosis and Management.
American family physician·2026
Scopolamine ameliorates psoriasis by blocking M1 receptor-mediated IL-23 production in dendritic cells.
Journal of immunology (Baltimore, Md. : 1950)·2026
Clinical Physiology of SGLT2 Inhibitors in Non-diabetic and Diabetic Individuals.
Handbook of experimental pharmacology·2026
Must RAAS-modifying drugs be withdrawn for the diagnosis of primary aldosteronism?
The Journal of clinical endocrinology and metabolism·2026
Combination Treatment of IL-17 Inhibitor and JAK Inhibitor in Psoriatic Arthritis: A Case Report and Scoping Review.
Immunity, inflammation and disease·2026